Associate Director, International Market Access, Oncology Pipeline

Company Description

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

Job Description

International Market Access & Pricing: Lead International market access strategies and prepare priority oncology assets for launch.

Reporting into the Hematology Pipeline Lead  (Director), this position will lead to international launch and lead additional hematology pipeline assets.

Core responsibilities include developing critical launch tools - Payor Value Message, Payor objection handler sand negotiation strategies to prepare affiliates for launch. This position will lead the Access Strategic Imperative group and work closely with the International Brand Team (INBT).

Additionally, the AD will leverage their payer knowledge alongside expertise of Evidence Based Medicine to shape pivotal development programs for enterprise critical pipeline assets.

Specific Responsibilities Include:

• Addressing pricing, reimbursement, access (PRA) potential across international key markets, including the EU5, CAN, JPN, AUS, BRA and China• Development of Early Integrated Value Proposition, aligned with the overall AbbVie Oncology Strategy, providing strategic direction for the Integrated Evidence Plan and Early Price Potential.
• Support global effort to integrate payer value messages into our clinical and evidence-base assessments and develop key market access deliverables in line with AbbVie’s framework and the asset playbook.
• Influence clinical development programs to ensure endpoints and trial design are incorporated that will optimize price, reimbursement and ultimately patient access globally.
• Proactively ensure reimbursement perspective is incorporated into early brand plans, disease area strategies and portfolio strategies throughout key clinical development miles